1. Göschke, H.: Spezies-Unterschiede bei der Wirkung von Monoaminoxydase-Hemmern. Arch. int. Pharmacodyn. 133, 245?253 (1961).
2. Lovenberg, W., R. J. Levine, and A. Sjoerdsma: A sensitive assay of monoamine oxidase activity in vitro: Application to heart and sympathetic ganglia. J. Pharmacol. exp. Ther. 135, 7?10 (1962).
3. Marshall, E. F., G. S. Stirling, A. C. Tait, and A. Todrick: The effect of iproniazid and imipramine on the blood platelet 5-hydroxytryptamine level in man. Brit. J. Pharmacol. 5, 35?41 (1960).
4. Paasonen, M. K.: Inactivation of 5-hydroxytryptamine by mammalian blood platelets. Biochem. Pharmacol. 8, 241?244 (1961).
5. ?, and E. Kivalo: The inactivation of 5-hydroxytryptamine by blood platelets in mental deficiency with elevated serum 5-hydroxytryptamine. Psychopharmacologia (Berl.) 3, 188?192 (1962).